You are in the accessibility menu

Statistics

Total Visits

Views
Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective. 69

Total Visits per Month

September 2024 October 2024 November 2024 December 2024 January 2025 February 2025 March 2025
Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective. 1 2 0 0 4 9 2

File Downloads

Views

Top Country Views

Views
Germany 23
United States 16
Russia 6
Brazil 5
China 5
Ukraine 4
France 1
Iraq 1
Japan 1
Poland 1

Top City Views

Views
Ashburn 6
Jacksonville 5
Nanjing 3
Ankara 1
Aptos 1
Baghdad 1
Belo Horizonte 1
Blue Bell 1
Conselheiro Lafaiete 1
Durham 1